Hemodynamic Predictors of Outcome Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
Circulation: Cardiovascular Interventions · 2023-08 · 16 (8)
DOI: 10.1161/circinterventions.123.013068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Cardiovascular Interventions, 2023-08. Verfasst von Mohamad S Alabdaljabar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Internal Medicine (M.S.A.), Mayo Clinic, Rochester, MN. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Cardiac Surgical Procedures, Ablation Techniques. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
BACKGROUND: Alcohol septal ablation (ASA) is a minimally invasive treatment for drug-refractory obstructive hypertrophic cardiomyopathy. Detailed assessment of pressure changes and predictors of mortality and procedure success are not well defined. METHODS: This is a single-center study evaluating pressure changes and predictors of mortality and procedure success in transseptal ASA. Survival analysis and predictors of mortality were assessed using the Kaplan-Meier analysis and Cox regression, respectively. RESULTS: A total of 156 patients were included (mean age, 67.3 years; 46.8% women). Left atrial (LA) pressure and left ventricular outflow tract (LVOT) gradient decreased, whereas aortic pulse pressure (PP) increased post-ASA. Patients with lower baseline mean LA pressure (82% (gradient change median), and PP increase >19% (PP change median) had superior survival. On Cox univariable regression, baseline mean LA pressure >median (19 mm Hg; hazard ratio [HR], 2.09 [95% CI, 1.05–4.18]; P =0.036), residual LVOT gradient (HR, 1.02 [95% CI, 1.01–1.03]; P =0.003), and LVOT gradient percent reduction median (28 mm Hg; HR, 2.36 [95% CI, 1.17–4.76]; P =0.016), baseline mean LA pressure >median (19 mm Hg; HR, 2.70 [95% CI, 1.33–5.50]; P =0.006), percentage reduction in gradient
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Internal Medicine (M.S.A.), Mayo Clinic, Rochester, MN.
- Cardiovascular Medicine (E.E.C., R.A.N., W.R.M., J.B.G., C.S.R., M.F.E.), Mayo Clinic, Rochester, MN.
ORCID-Profile: Mohamad S Alabdaljabar, Emily E Cendrowski, Rick A Nishimura, William R Miranda, Charanjit S Rihal, Mackram F Eleid
Zitieren
APA
Alabdaljabar, M. S., Cendrowski, E. E., Nishimura, R. A., Miranda, W. R., Geske, J. B., Rihal, C. S., & Eleid, M. F. (2023). Hemodynamic Predictors of Outcome Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. Circulation: Cardiovascular Interventions, 16(8). https://doi.org/10.1161/circinterventions.123.013068
Vancouver
Alabdaljabar MS, Cendrowski EE, Nishimura RA, Miranda WR, Geske JB, Rihal CS, et al. Hemodynamic Predictors of Outcome Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. Circulation: Cardiovascular Interventions. 2023;16(8). doi:10.1161/circinterventions.123.013068
BibTeX
@article{Alabdaljabar2023,
author = {Alabdaljabar, Mohamad S and Cendrowski, Emily E and Nishimura, Rick A and Miranda, William R and Geske, Jeffrey B and Rihal, Charanjit S and Eleid, Mackram F},
title = {Hemodynamic Predictors of Outcome Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy},
journal = {Circulation: Cardiovascular Interventions},
year = {2023},
volume = {16},
number = {8},
doi = {10.1161/circinterventions.123.013068}
}
EUVIMED